Jane Street’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-27,100
Closed -$2.5M 6227
2019
Q2
$2.5M Sell
27,100
-940,000
-97% -$89.3M ﹤0.01% 1661
2019
Q1
$91.2M Buy
967,100
+611,300
+172% +$53.5M 0.15% 96
2018
Q4
$22.8M Buy
355,800
+88,100
+33% +$6.5M 0.05% 275
2018
Q3
$24M Sell
267,700
-239,800
-47% -$21.2M 0.05% 286
2018
Q2
$40.3M Buy
507,500
+330,400
+187% +$27.4M 0.09% 152
2018
Q1
$15.8M Buy
177,100
+12,100
+7% +$1.16M 0.04% 371
2017
Q4
$17.2M Sell
165,000
-104,400
-39% -$11.8M 0.05% 328
2017
Q3
$39.3M Sell
269,400
-465,900
-63% -$63.5M 0.13% 153
2017
Q2
$95.5M Sell
735,300
-94,100
-11% -$11.5M 0.33% 52
2017
Q1
$103M Buy
829,400
+531,800
+179% +$63.6M 0.46% 34
2016
Q4
$34.4M Buy
297,600
+80,500
+37% +$8.96M 0.15% 112
2016
Q3
$22.7M Sell
217,100
-320,600
-60% -$34.7M 0.11% 168
2016
Q2
$53M Buy
537,700
+307,800
+134% +$31.8M 0.26% 67
2016
Q1
$23M Buy
229,900
+69,400
+43% +$7.15M 0.13% 148
2015
Q4
$19.2M Buy
160,500
+38,300
+31% +$4.43M 0.12% 148
2015
Q3
$13.2M Buy
122,200
+85,800
+236% +$10.6M 0.08% 197
2015
Q2
$4.21M Sell
36,400
-137,800
-79% -$15.8M 0.03% 559
2015
Q1
$20.1M Buy
174,200
+142,900
+457% +$17.1M 0.16% 111
2014
Q4
$3.5M Buy
+31,300
New +$3.3M 0.03% 453

Other funds holding CELG

Jane Street's CELG Position: Q4 2019 in Review

Jane Street sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 36,809 shares — an estimated $3.66M sold.

Jane Street first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $63.8M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Jane Street reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Jane Street sold 36,809 Celgene Corp shares in Q4 2019, an estimated $3.66M.
  • Jane Street first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Jane Street's Celgene Corp position peaked at $63.8M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Jane Street's 13F filing for Q4 2019, filed 14 Feb 2020.